[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336156-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336156-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","amlodipine-inhibits-synaptotagmin-4s-oncogenic-activity-on-gastric-cancer-proliferation-by-targeting-calcium-signaling","Amlodipine inhibits Synaptotagmin-4’s oncogenic activity on gastric cancer proliferation by targeting calcium signaling","","Gastric cancer remains a major global cause of cancer mortality, and synaptotagmin-4 (SYT4), a calcium-sensing synaptic vesicle protein, is investigated for its role in tumor progression. The study assesses SYT4 expression in gastric cancer tissues using bioinformatics and immunohistochemistry, then links SYT4 to clinical outcomes through univariate and multivariate prognostic analyses. Cellular and in vivo experiments show SYT4 promotes proliferation, suppresses apoptosis, and increases Ca2+ influx via MAPK activation. Amlodipine pretreatment suppresses MAPK signaling, reduces SYT4-driven growth, and enhances apoptosis, supporting therapeutic potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/amlodipine-inhibits-synaptotagmin-4s-oncogenic-activity-on-gastric-cancer-proliferation-by-targeting-calcium-signaling/336156/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/amlodipine-inhibits-synaptotagmin-4s-oncogenic-activity-on-gastric-cancer-proliferation-by-targeting-calcium-signaling/336156.png","ImageObject",300,407,{"name":42,"@type":43},"Ava Thompson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of this study?","Question",{"text":63,"@type":64},"To define how synaptotagmin-4 (SYT4) influences clinical outcomes and biological behaviors in gastric cancer, with emphasis on calcium signaling mechanisms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was SYT4 expression evaluated in gastric cancer?",{"text":68,"@type":64},"SYT4 levels were examined in gastric cancer specimens using bioinformatics analyses and immunohistochemistry.",{"name":70,"@type":61,"acceptedAnswer":71},"What effect does amlodipine have on SYT4-driven gastric cancer activity?",{"text":72,"@type":64},"Amlodipine pretreatment attenuates SYT4-associated cell growth, potentiates apoptosis, and suppresses MAPK pathway activity in support of antitumor effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336156,1790219835,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","Functional & Integrative Genomics (2024) 24:77 [https://doi.org/10.1007/s10142-024-01345-8](https://doi.org/10.1007/s10142-024-01345-8)  \nORIGINAL ARTICLE  \nAmlodipine inhibits Synaptotagmin-4’s oncogenic activity on gastric cancer proliferation by targeting calcium signaling  \nWen Huang1 · Shuo Yang2,3 · Minying Deng1 · Rongkui Luo1 · Huaiyu Liang1 · Yanyan Shen4 · Biyu Yang4 · Chen Xu1 · Yingyong Hou1  \nReceived: 15 January 2024 / Revised: 13 March 2024 / Accepted: 18 March 2024 / Published online: 18 April 2024 © The Author(s) 2024  \nAbstract  \nBackground: Gastric cancer (GC) remains a leading cause of cancer mortality globally. Synaptotagmin-4 (SYT4), a calcium-sensing synaptic vesicle protein, has been implicated in the oncogenesis of diverse malignancies. Purpose: This study delineates the role of SYT4 in modulating clinical outcomes and biological behaviors in GC. Methods: We evaluated SYT4 expression in GC specimens using bioinformatics analyses and immunohistochemistry. Functional assays included CCK8 proliferation tests, apoptosis assays via flow cytometry, confocal calcium imaging, and xenograft models. Western blotting elucidated MAPK pathway involvement. Additionally, we investigated the impact of the calcium channel blocker amlodipine on cellular dynamics and MAPK pathway activity. Results: SYT4 was higher in GC tissues, and the elevated SYT4 was significantly correlated with adverse prognosis. Both univariate and multivariate analyses confirmed SYT4 as an independent prognostic indicator for GC. Functionally, SYT4 promoted tumorigenesis by fostering cellular proliferation, inhibiting apoptosis, and enhancing intracellular Ca2+ influx, predominantly via MAPK pathway activation. Amlodipine pre-treatment attenuated SYT4-driven cell growth and potentiated apoptosis, corroborated by in vivo xenograft assessments. These effects were attributed to MAPK pathway suppression by amlodipine. Conclusion: SYT4 emerges as a potential prognostic biomarker and a pro-oncogenic mediator in GC through a Ca2+-dependent MAPK mechanism. Amlodipine demonstrates significant antitumor effects against SYT4-driven GC, positing its therapeutic promise. This study underscores the imperative of targeting calcium signaling in GC treatment strategies.  \nKeywords Gastric cancer · synaptotagmin-4 · Calcium ion channel · Mitogen-activated protein kinase signaling pathway · Amlodipine  \nWen Huang and Shuo Yang contributed equally to this work.  \n􀀍 Chen Xu [xuchen1251@yeah.net](xuchen1251@yeah.net)  \n􀀍 Yingyong Hou [houyingyong@hotmail.com](houyingyong@hotmail.com)  \n1 Department of Pathology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Xuhui District, Shanghai 200032, China  \n2 Department of Orthopaedics, People’s Hospital of Tongzhou Bay Demonstration Zone, Nantong, Jiangsu, China  \n3 Department of Orthopaedics, Nantong First People’s Hospital, Affiliated Hospital 2 of Nantong University, Nantong, Jiangsu, China  \n4 Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China  \nIntroduction  \nGastric cancer (GC) is a leading cause of cancer mortality worldwide, attributed to its genetic complexity and aggressive behavior (.Gao et al. 2015) . According to the International Agency for Research on Cancer’s 2020 Cancer Burden data, GC accounts for the sixth in incidence and the third in mortality among all malignancies(.Sung et al. 2021) . The 2016 cancer statistics estimated that approximately 397,000 new cases of GC were diagnosed in China each year, with about 289,000 deaths, ranking the third in both incidence and mortality (.Zheng et al. 2022) . The disease’s heterogeneity and the advanced stage at which it is typically diagnosed contribute to a persistently low 5-year survival rate (.Ji et al. 2004), underscoring the urgent need for novel prognostic biomarkers and more effective therapeutic strategies.  \nRecent studies highlight the significance of ion channels, particularly those involved in Ca2+ signali","cbCailZB0Fc6ZNPI","https://ap.wps.com/l/cbCailZB0Fc6ZNPI","pdf",9134857,14,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main purpose of this study?\",\"answer\":\"To define how synaptotagmin-4 (SYT4) influences clinical outcomes and biological behaviors in gastric cancer, with emphasis on calcium signaling mechanisms.\"},{\"question\":\"How was SYT4 expression evaluated in gastric cancer?\",\"answer\":\"SYT4 levels were examined in gastric cancer specimens using bioinformatics analyses and immunohistochemistry.\"},{\"question\":\"What effect does amlodipine have on SYT4-driven gastric cancer activity?\",\"answer\":\"Amlodipine pretreatment attenuates SYT4-associated cell growth, potentiates apoptosis, and suppresses MAPK pathway activity in support of antitumor effects.\"}]","Amlodipine inhibits Synaptotagmin-4’s oncogenic activity on gastric cancer proliferation by targeting calcium signaling | PDF",1790013927,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/106ddb85b030cd008c1e9dcb5e98e4ed.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10288506e813590cf2f60a7105d47b7f.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bab7a2137e53cfff7e5ba3ce2d72e168.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b00300dc0c313f292aa12027f7d38ab3.webp",980,1301]